SCHEMBL2618792

SCHEMBL2618792

O=[N+]([O-])c1ccccc1-c1ccc2c(c1)C(c1ccccc1)(c1ccccc1)c1cc(-c3ccccc3)ccc1-2

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
EIF4E P06730 10/20 0.41
ADORA1 P30542 1/20 0.41
MAPT P10636 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
PDK2 Q15119 1/20 0.40
PTPN1 P18031 1/20 0.38
MAOB P27338 1/20 0.37
HPRT1 P00492 1/20 0.37
TDP2 O95551 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2618787 0.93 ALDH1A1 (0.53) ALDH1A1TDP1EIF4EADORA1MAPT
SCHEMBL16373520 0.84 ALDH1A1 (0.54) ALDH1A1TDP1EIF4EADORA1MAPT
SCHEMBL16800913 0.83 ALDH1A1 (0.62) ALDH1A1TDP1ADORA1MAPTPTPN1
SCHEMBL26014229 0.83 ALDH1A1 (0.44) ALDH1A1TDP1EIF4EADORA1MAPT
SCHEMBL18787205 0.80 ALDH1A1 (0.44) ALDH1A1TDP1EIF4EADORA1MAPT
SCHEMBL19411350 0.80 ALDH1A1 (0.50) ALDH1A1TDP1EIF4EADORA1MAPT
SCHEMBL4142462 0.79 TDP1 (0.75) ALDH1A1TDP1MAPTCRHBPCRHR2
SCHEMBL26825403 0.79 PDK2 (0.54) MAPTPDK2TDP2
SCHEMBL26014232 0.79 ALDH1A1 (0.49) ALDH1A1TDP1EIF4EADORA1MAPT
SCHEMBL2958562 0.77 ALDH1A1 (0.92) ALDH1A1TDP1CRHBPCRHR2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9017827-B2 Indenocarbazole compound for optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2015-04-28 US disclosed
US-9017827-B2 Indenocarbazole compound for optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2015-04-28 US disclosed
US-20120091446-A1 COMPOUND FOR OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-04-19 US disclosed
US-20120091446-A1 COMPOUND FOR OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120091446-A1 COMPOUND FOR OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, OR10J3, AOX1 ALDH1A1 16/4885TDP1 3980/4885EIF4E 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.